KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?

W Zhang; M J Labonte; H-J Lenz; Melissa LaBonte Wilson

doi:10.1093/annonc/mdq704

KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?

W Zhang, M J Labonte, H-J Lenz, Melissa LaBonte Wilson

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	484-5
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	22
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdq704
Publication status	Published - Feb 2011

Keywords

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Codon
Colorectal Neoplasms
Genes, ras
Humans
Mutation
Neoplasm Metastasis
Polymorphism, Single Nucleotide

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdq704

Cite this

@article{c5559a36759b4cb689a967f3a290f2d3,

title = "KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?",

keywords = "Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Codon, Colorectal Neoplasms, Genes, ras, Humans, Mutation, Neoplasm Metastasis, Polymorphism, Single Nucleotide",

author = "W Zhang and Labonte, {M J} and H-J Lenz and {LaBonte Wilson}, Melissa",

year = "2011",

month = feb,

doi = "10.1093/annonc/mdq704",

language = "English",

volume = "22",

pages = "484--5",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "2",

}